Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Pinsky

Showing results (281-290 of 291) with videos related to

Pageof 30
Sort By:
Biorxiv : the Preprint Server for Biology|February 17, 2021
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2022
Disease diagnostics using machine learning of immune receptorsMaxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 DiseaseGeidy E Serrano, Jessica E Walker, Richard Arce, et al.
Science Translational Medicine|September 3, 2025
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteinsSanjeev Kumar, Shilpi Jain, Bushra Wali, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Journal of the National Cancer Institute|February 1, 2023
Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regionsW K Jacky Lam, Ann D King, Jacob A Miller, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Medrxiv : the Preprint Server for Health Sciences|August 9, 2020
High-throughput SARS-CoV-2 and host genome sequencing from single nasopharyngeal swabsJohn E Gorzynski, Hannah N De Jong, David Amar, et al.
Nature Genetics|July 25, 2022
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infectionScott B Biering, Sylvia A Sarnik, Eleanor Wang, et al.
Journal of Neuropathology and Experimental Neurology|July 12, 2022
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19Geidy E Serrano, Jessica E Walker, Cécilia Tremblay, et al.
Pageof 30

Showing results (281-290 of 291) with videos related to

Sort By:
Pageof 30
Biorxiv : the Preprint Server for Biology|February 17, 2021
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2022
Disease diagnostics using machine learning of immune receptorsMaxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 DiseaseGeidy E Serrano, Jessica E Walker, Richard Arce, et al.
Science Translational Medicine|September 3, 2025
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteinsSanjeev Kumar, Shilpi Jain, Bushra Wali, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Journal of the National Cancer Institute|February 1, 2023
Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regionsW K Jacky Lam, Ann D King, Jacob A Miller, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Medrxiv : the Preprint Server for Health Sciences|August 9, 2020
High-throughput SARS-CoV-2 and host genome sequencing from single nasopharyngeal swabsJohn E Gorzynski, Hannah N De Jong, David Amar, et al.
Nature Genetics|July 25, 2022
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infectionScott B Biering, Sylvia A Sarnik, Eleanor Wang, et al.
Journal of Neuropathology and Experimental Neurology|July 12, 2022
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19Geidy E Serrano, Jessica E Walker, Cécilia Tremblay, et al.
Pageof 30